Predominance of Candida Glabrata among Non- albicans Candida Species in a 16-Year Study of Candidemia at a Tertiary Care Center in Lebanon
- PMID: 33477771
- PMCID: PMC7832319
- DOI: 10.3390/pathogens10010082
Predominance of Candida Glabrata among Non- albicans Candida Species in a 16-Year Study of Candidemia at a Tertiary Care Center in Lebanon
Abstract
Candidemia is associated with a high mortality rate, and its incidence is increasing worldwide with a rise in non-albicans candidemia (NAC). Epidemiologic data from Arab countries are scarce and there are no data from Lebanon; Methods: This is a single-center retrospective chart review of patients with candidemia in a tertiary care center in Lebanon from 2004 to 2019. We extracted data on patient characteristics, isolated Candida species antifungal susceptibility, management and outcomes; Results: We included 170 cases of candidemia. NAC was more common than albicans candidemia (64.7% vs. 35.3%). C. glabrata was the most common non-albicans species (37 isolates) followed by C. tropicalis (14). Recent use of antifungals was a risk factor for NAC (OR = 2.8, p = 0.01), while the presence of a central venous catheter was protective (OR = 0.41, p = 0.02). Fluconazole resistance was 12.5% in C. albicans and 21.5% in non-albicans spp. Mortality at 30 days was 55.5%, with no difference between NAC and albicans candidemia. It was higher in older and critically ill patients but lower in patients whose central venous catheter was removed after detecting fungemia; Conclusions: Candidemia is associated with high mortality in Lebanon, with a predominance of NAC and high prevalence of C. glabrata.
Keywords: Arab world; Candida glabrata; Lebanon; antifungal susceptibility; candidemia; invasive candidiasis; non-albicans Candida.
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Lortholary O., Renaudat C., Sitbon K., Madec Y., Denoeud-Ndam L., Wolff M., Fontanet A., Bretagne S., Dromer F. Worrisome Trends in Incidence and Mortality of Candidemia in Intensive Care Units (Paris Area, 2002–2010) Intensive Care Med. 2014;40:1303–1312. doi: 10.1007/s00134-014-3408-3. - DOI - PMC - PubMed
-
- Paiva J.-A., Pereira J.M., Tabah A., Mikstacki A., de Carvalho F.B., Koulenti D., Ruckly S., Çakar N., Misset B., Dimopoulos G., et al. Characteristics and Risk Factors for 28-Day Mortality of Hospital Acquired Fungemias in ICUs: Data from the EUROBACT Study. Crit. Care. 2016;20 doi: 10.1186/s13054-016-1229-1. - DOI - PMC - PubMed
-
- Colombo A.L., Guimarães T., Sukienik T., Pasqualotto A.C., Andreotti R., Queiroz-Telles F., Nouér S.A., Nucci M. Prognostic Factors and Historical Trends in the Epidemiology of Candidemia in Critically Ill Patients: An Analysis of Five Multicenter Studies Sequentially Conducted over a 9-Year Period. Intensive Care Med. 2014;40:1489–1498. doi: 10.1007/s00134-014-3400-y. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous